Wednesday, 23 August 2017

Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market

ResearchMoz added Latest Research Report titled " Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market " to it's Large Report database.

The respiratory therapy area consists of indications that affect the respiratory system in various ways, including the scarring of lung tissue and excessive production of mucus in the airways, thereby decreasing lung function. The causes of respiratory disorders vary significantly between indications, with potential causes including infection, vascular damage or dysfunction, aging, environmental stressors such as pollution, and genetic predisposition.

The treatment landscape for respiratory disorders has traditionally been dominated by small molecule therapies that treat the disease symptoms rather than the cause. This means that treatment options can be diverse in terms of their targets and mechanisms of action. This is most notable in cystic fibrosis (CF), where patients may be prescribed a combination of drugs from several treatment categories, including mucolytic agents, bronchodilators and antibiotics. The chronic obstructive pulmonary disease (COPD) and asthma treatment landscapes employ similar symptomatic treatments, including bronchodilators and inhaled corticosteroids.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1049124

The respiratory therapy area contains numerous primary indications, including asthma, COPD, CF and idiopathic pulmonary fibrosis (IPF), which have large prevalent populations. In addition, there are many secondary respiratory conditions that have smaller prevalent populations yet significant unmet clinical needs. This report focuses on these secondary respiratory conditions, particularly pneumonia, respiratory syncytial virus (RSV), pulmonary arterial hypertension (PAH) and tuberculosis (TB).

A major cause of secondary respiratory disease is infections caused by bacteria or viruses. Bacterial infections, such as pneumonia and TB, and viral infections, such as RSV, cause infection of the lungs. The immune system response to these infections causes inflammation that interferes with the ability of the lungs to function. Cardiovascular problems also represent another major cause of respiratory complications. PAH in particular represents a profound risk factor for cardiovascular events in the pulmonary vascular system, including pulmonary embolism.

Browse more details @ http://www.researchmoz.us/global-respiratory-complications-therapeutics-market-report.html

Table of Contents

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 8

2 Introduction 10
2.1 Therapy Area Introduction 10
2.2 Symptoms 10
2.2.1 Pneumonia 10
2.2.2 RSV 10
2.2.3 PAH 11
2.2.4 Tuberculosis 11
2.3 Diagnosis 11
2.3.1 Pneumonia 11
2.3.2 RSV 11
2.3.3 PAH 12
2.3.4 Tuberculosis 12
2.4 Etiology and Pathophysiology 12
2.4.1 Pneumonia 14
2.4.2 RSV 14
2.4.3 PAH 15
2.4.4 Tuberculosis 16

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/

Frontier Pharma: Fatty Liver Disease - High Degree of First-in-Class Innovation, Dominated by Nuclear Receptor-Targeting NASH Products

ResearchMoz added Latest Research Report titled " Frontier Pharma: Fatty Liver Disease - High Degree of First-in-Class Innovation, Dominated by Nuclear Receptor-Targeting NASH Products " to it's Large Report database.

Fatty liver disease (FLD) comprises a spectrum of chronic liver disorders characterized by excessive lipid accumulation in the liver (steatosis), which may lead to inflammation (steatohepatitis) and fibrosis. It has the potential to progress to end-stage liver diseases such as cirrhosis, liver cancer and liver failure, and is also associated with numerous complications and co-morbidities, including cardiovascular and metabolic diseases. FLD can be divided into non-alcoholic FLD (NAFLD) and alcoholic FLD (AFLD), depending on the patent’s history of alcohol use.

FLD is the most common chronic liver disease in the world, and its global prevalence has increased rapidly in the past several decades. The worldwide prevalence of FLD is estimated at 20–45% in the general population, and up to 90% in obese patients. There is a broad consensus to describe the condition as the hepatic manifestation of metabolic syndrome, and it is closely associated with obesity, diabetes and dyslipidemia. NAFLD has become the main driver of the rapid growth of FLD prevalence, mainly due to the rising prevalence of obesity.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1065937

FLD is increasingly recognized as a major global health problem. However, despite this the FLD market is still in its infancy, with no FDA-approved drugs for this indication, and only a limited number of generic drugs approved in non-US markets in recent years.

Due to the increasing health burden of FLD and the lack of therapeutic options, there is a pressing need to develop pharmacological strategies. This is especially the case for patients with steatohepatitis, who are at the greatest risk of developing cirrhosis or liver cancer, which can lead to liver failure. Due to the pathophysiological complexity of FLD and its diverse population, different therapeutic agents are likely to be needed to tackle the lipotoxicity, inflammation and fibrogenesis that drive FLD progression.

FLD has an active pipeline and first-in-class products account for a considerable proportion, which is very promising considering the level of unmet need and lack of approved treatment options. First-in-class innovation is concentrated heavily at the early drug development stages, and prominent first-in-class molecular targets include nuclear receptors, immune mediators, and molecules involved in lipid synthesis. Additionally, the first-in-class targets identified show considerable diversity, reflecting the multifaceted aspects of FLD pathophysiology.

Browse more details @ http://www.researchmoz.us/frontier-pharma-fatty-liver-disease-high-degree-of-firstinclass-innovation-dominated-by-nuclear-receptortargeting-nash-products-report.html

Table of Contents

1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3

2 Executive Summary 5
2.1 Urgent Unmet Need Driven By Rising Prevalence 5
2.2 High Degree of First-in-Class Innovation 5
2.3 Rising Deal Volumes and Considerable Investment Opportunities in First-in-Class Product Development 5

3 The Case for Innovation 6
3.1 Growing Opportunities for Biologic Products 7
3.2 Diversification of Molecular Targets 7
3.3 Innovative First-in-Class Development Remains Attractive 7
3.4 Regulatory and Reimbursement Policy Shifts Favor First-in-Class Product Innovation 8
3.5 Sustained Innovation 8
3.6 GBI Research Report Guidance 8

4 Clinical and Commercial Landscape 10
4.1 Disease Overview 10
4.2 Disease Symptoms 11
4.3 Epidemiology 11
4.4 Etiology and Risk Factors 11
4.4.1 Environmental Factors 11
4.4.2 Host Factors 12

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/

Pharmaceutical Lifecycle Management Strategies in 2017 - Comprehensive Assessment Of Strategies Being Implemented By Pharmaceutical Companies Around The World

ResearchMoz added Latest Research Report titled " Pharmaceutical Lifecycle Management Strategies in 2017 " to it's Large Report database.

GBI Research’s latest report, ""Pharmaceutical Lifecycle Management Strategies in 2017"" provides a comprehensive assessment of product lifecycle (LCM) management strategies that are being implemented by pharmaceutical companies around the world. The pharmaceutical industry remains highly competitive and lucrative, and companies are investing significant time and resources into implementing strategies aimed at preserving the revenue streams of their products by extending patent life, delaying competition or slowing the pace of revenue loss following the end of market exclusivity.

The study, delivered in the form of an 82-slide PowerPoint presentation investigates a wide range of commercial, developmental, legal and regulatory strategies. This report format allows you to easily assemble high-quality presentations and research material to meet a variety of corporate requirements. Our research deep dives into the rationale for implementing LCM strategies, as well as the challenges, risks and commercial opportunities they represent. Moreover, detailed case studies showcasing recent real-world examples of LCM strategies will enable understanding of the key factors that determined their success. Information leveraged from our robust industry-leading database also highlights strategies being implemented for products currently in development.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1065938

The pharmaceutical industry will continue to face a wide range of challenges in the coming years, including patent cliffs, declining productivity, intensifying levels of competition from generic and biosimilar manufacturers, low reimbursement levels and stricter regulatory policies. Careful LCM planning will continue to be a crucial element of the industry’s ability to answer these problems.

GBI Research conducted extensive research to provide a comprehensive understanding of the LCM strategies being implemented by players in the pharmaceutical industry. This new report adds to our unique portfolio of trusted industry analyses that enable our clients to assess the most promising commercial areas in the market and exploit key business opportunities.

Scope
  • What is driving the need for effective LCM strategies in the pharmaceutical industry?
  • What are the most common LCM strategies being implemented?
  • What are the business opportunities and commercial rewards arising from the implementation of LCM strategies?
  • What are the key factors that impact the choice of LCM strategy?
  • What strategies have Big Pharma companies implemented in recent years to preserve revenues and market share?
Browse more details @ http://www.researchmoz.us/pharmaceutical-lifecycle-management-strategies-in-2017-report.html

Table of contents

1. Introduction

2. Executive Summary

3. Introduction to Pharmaceutical Lifecycle Management Strategies
3.1 The Pharmaceutical Product Lifecycle Curve
3.2 Key Objectives of Life Cycle Management Strategies in the
Pharmaceutical Industry
3.3 What is Driving the Need for Effective Lifecycle Management
Strategies in the Pharmaceutical Industry?
3.4 Classification and Benefits of Different Lifecycle Management
Strategies for Pharma
3.5 Business Opportunities Created by LCM Strategies
3.6 Factors Impacting Choice of Lifecycle Strategies

4. Pharmaceutical Lifecycle Management – Commercial Strategies
4.1 Rx-to-OTC Switch as an LCM Strategy
4.1.1 RX-to-OTC Switch Case Studies
4.2 Geographical Expansion
4.3 Contract Research Organizations Helping Overcome Industry Challenges
4.3.1 Benefits from Partnering with Contract Development and
Manufacturing Organizations (CDMOs)
4.3.2 Strategic Partnerships with CROs: Case studies

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/

Europe Molecular Diagnostics Market - Industry Analysis, Regulatory Approval Process, Volume, Growth, Trends and Forecast 2017 - 2025

ResearchMoz added Latest Research Report titled " Molecular Diagnostics Market - Europe Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017 - 2025 " to it's Large Report database.

Europe Molecular Diagnostics Market: Overview

Molecular diagnostics market employs a range of systems, including real-time PCR systems, liquid handling systems, and DNA extraction systems, among others. Real-time PCR systems are commonly known as quantitative PCR systems. These systems monitor the amplification of the targeted DNA molecule during the exponential phase. The commonly used detection methods in these systems include fluorescent dyes and sequence specific DNA probes. The basic components of these systems include thermal cycler for automating the temperature cycling required in the PCR; optical systems for detection; and software to control the instrument and analyze the data. Liquid handling systems are used to dispense selected quantity of reagents, liquids, or samples to a container. These systems work on the principle of suction and are available as single or multi-channel systems. DNA Extraction systems are employed for streamlining the process of DNA extraction and automatic extraction of DNA from a variety of samples. These systems are employed as they are less time consuming, more efficient than the manual methods, and less prone to analytical errors.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1166567

Europe Molecular Diagnostics Market: Research Methodologies

The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue and volume of molecular diagnostics systems in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. The report provides estimated market size in terms of US$ Mn and volume in terms of units for each products and end-user. In addition, the report provides estimated market size in terms of US$ Mn for various geographic regions in Europe for the period 2015 to 2025, considering the macro and micro environmental factors. The revenue generated from each product was calculated by considering their launch date in the market, customer acceptance, volume sales, price of the product, trends in industry, end user trend, and adoption rate across all the geographies.

Browse more details @ http://www.researchmoz.us/molecular-diagnostics-market-europe-industry-analysis-size-share-volume-growth-trends-and-forecast-2017-2025-report.html

Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Europe Molecular Diagnostics Market

4. Market Overview
4.1. Introduction
4.2. Key Market Indicators
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity
4.4. Europe Molecular Diagnostics Market Analysis and Forecasts, 2015–2025
4.4.1. Market Revenue (US$ Mn) and Volume (units) Projections
4.4.2. Installed Base- Global (units)
4.5. Porter’s Five Force Analysis
4.6. Value Chain Analysis
4.8. Regulatory approval process
4.9. Market Outlook

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/

Global Thin Film Drug Manufacturing Market to be Worth US$15,984.3 Billion by 2024 - Industry Analysis, Size, Share, Growth, Trends & Forecast

ResearchMoz added Latest Research Report titled " Thin Film Drug Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2016 - 2024 " to it's Large Report database.

Global Thin Film Drug Manufacturing Market: Overview

This report on thin film drug manufacturing market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of thin film drug manufacturing products such as oral thin film, transdermal thin film and others as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global thin film drug manufacturing market with respect to the leading market segments based on major disease indication segment, products segment, distribution channels, and geographies.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1166458

Global Thin Film Drug Manufacturing Market: Segmentation

Based on the product type, the thin film drug manufacturing market has been segmented into: oral thin film, transdermal thin film and others. Each of the market segments have been extensively analyzed based on the market related factors such as increasing demand of thin film drug manufacturing products worldwide, and technological advancement. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2014 to 2024. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2016 to 2024, considering 2015 as the base year.

Browse more details @ http://www.researchmoz.us/thin-film-drug-manufacturing-market-global-industry-analysis-size-share-growth-trends-forecast-2016-2024-report.html

Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary

4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Key Market Indicators
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunity
4.5. Global Thin Film Drug ManufacturingAnalysis and Forecasts, 2016–2024
4.6. Thin Film Drug Manufacturing- Global Supply Demand Scenario
4.7. Porter’s Five Force Analysis
4.8. Value Chain Analysis
4.9. Market Outlook

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/

Tuesday, 22 August 2017

Demand in United States Uterine Fibroids Treatment Market Report 2017 - Top Players are Blue Endo, Karl Storz, Halt Medical, LiNA Medical etc.

ResearchMoz added Latest Research Report titled " United States Uterine Fibroids Treatment Market Report 2017 " to it's Large Report database.

This report studies sales (consumption) of Uterine Fibroids Treatment in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Blue Endo
Boston Scientific Corporation
Karl Storz
Halt Medical, Inc.
LiNA Medical USA
Merit Medical Systems
Olympus Corporation
Richard Wolf GmbH

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=976733

Market Segment by States, covering
California
Texas
New York
Florida
Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III

Browse more details @ http://www.researchmoz.us/united-states-uterine-fibroids-treatment-market-report-2017-report.html

Table of Contents

1 Uterine Fibroids Treatment Overview
1.1 Product Overview and Scope of Uterine Fibroids Treatment
1.2 Classification of Uterine Fibroids Treatment
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Uterine Fibroids Treatment
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Uterine Fibroids Treatment (2011-2021)
1.4.1 United States Uterine Fibroids Treatment Sales and Growth Rate (2011-2021)
1.4.2 United States Uterine Fibroids Treatment Revenue and Growth Rate (2011-2021)

2 United States Uterine Fibroids Treatment Competition by Manufacturers
2.1 United States Uterine Fibroids Treatment Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Uterine Fibroids Treatment Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Uterine Fibroids Treatment Average Price by Manufactures (2015 and 2016)
2.4 Uterine Fibroids Treatment Market Competitive Situation and Trends
2.4.1 Uterine Fibroids Treatment Market Concentration Rate
2.4.2 Uterine Fibroids Treatment Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/

Industry Highlights: Global Consumer Healthcare Market Research Report 2017 - Key Manufacturer like Merck, Pfizer, Sanofi, GlaxoSmithKline etc.

ResearchMoz added Latest Research Report titled " Global Consumer Healthcare Market Research Report 2017 " to it's Large Report database.

Notes:
Production, means the output of Consumer Healthcare
Revenue, means the sales value of Consumer Healthcare

This report studies Consumer Healthcare in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
Johnson & Johnson
Bayer Healthcare
GlaxoSmithKline
Sanofi
Pfizer
Boehringer Ingelheim
Merck
Mitsubishi Tanabe Pharma

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=979041

Sun Pharma
Taisho Pharmaceuticals
Takeda Pharmaceuticals
Vida Laboratories
Omega Pharma
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Consumer Healthcare in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India

Browse more details @ http://www.researchmoz.us/global-consumer-healthcare-market-research-report-2017-report.html

Table of Contents

Global Consumer Healthcare Market Research Report 2017
1 Consumer Healthcare Market Overview
1.1 Product Overview and Scope of Consumer Healthcare
1.2 Consumer Healthcare Segment by Type
1.2.1 Global Production Market Share of Consumer Healthcare by Type in 2015
1.2.2 OTC Pharmaceuticals
1.2.3 Dietary Supplements
1.3 Consumer Healthcare Segment by Application
1.3.1 Consumer Healthcare Consumption Market Share by Application in 2015
1.3.2 Hospital
1.3.3 Drugstore
1.4 Consumer Healthcare Market by Region
1.4.1 North America Status and Prospect (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 China Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Consumer Healthcare (2012-2022)

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/